The risk and added values of the atherosclerotic cardiovascular risk enhancers on prediction of cardiovascular events: Tehran lipid and glucose study

BACKGROUND: In 2013 American College of Cardiology and the American Heart Association released a guideline on the management of atherosclerotic cardiovascular disease (ASCVD) including a composite of death from CVD, non-fatal myocardial infarction, or non-fatal stroke (hard CVD). This guideline reco...

Descripción completa

Detalles Bibliográficos
Autores principales: Hadaegh, Farzad, Asgari, Samaneh, Moosaie, Fatemeh, Orangi, Meysam, Sarvghadi, Farzaneh, Khalili, Davood, Azizi, Fereidoun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789723/
https://www.ncbi.nlm.nih.gov/pubmed/33407576
http://dx.doi.org/10.1186/s12967-020-02686-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789723/
https://www.ncbi.nlm.nih.gov/pubmed/33407576
http://dx.doi.org/10.1186/s12967-020-02686-1

Ejemplares similares